10 research outputs found

    Current status of fox rabies in Europe

    Get PDF
    There was a general decline in animal rabies in Europe in 1991 following the peak levels which occurred in 1989. This was ascribed, in France at least, to the normal decline in cases usually experienced following peak occurrence and also to oral immunization of foxes against rabies. European countries in which rabies occurs may be infected by fox, insectivorous bat or dog rabies. This paper makes a general summary of the rabies situation in Europe in 1991 and presents data obtained in 1991 from 15 European countries using oral vaccination against fox rabies.The articles have been scanned in colour with a HP Scanjet 5590; 600dpi. Adobe Acrobat XI Pro was used to OCR the text and also for the merging and conversion to the final presentation PDF-format.mn201

    SAG-2 oral rabies vaccine

    Get PDF
    The live modified rabies virus vaccine strain SAG-2 was selected from SAD Berne in a two step process employing anti-rabies glycoprotein monoclonal antibodies. The first two nucleotides coding for the amino acid in position 333 of the rabies glycoprotein are mutated. Arginine at position 333, which is associated with rabies pathogenicity, was substituted first by lysine and then by glutamic acid. The two nucleotide differences at position 333 in SAG-2 to any of six possible arginine triplets translated into excellent genetic stability and apathogenicity for adult mice, foxes, cats and dogs. The vaccination of foxes and dogs by the oral route provided protection against a lethal challenge with rabies virus.The articles have been scanned in colour with a HP Scanjet 5590; 600dpi. Adobe Acrobat XI Pro was used to OCR the text and also for the merging and conversion to the final presentation PDF-format.mn201

    Humoral immunity after anti-rabies vaccination

    No full text
    Le niveau de l’immunitĂ© humorale aprĂšs vaccination contre la rage a Ă©tĂ© comparĂ© chez l’homme et quatre espĂšces animales (singes, chiens, renards, bovins) au cours de 258 titrages sĂ©rologiques. AprĂšs une injection (de primo-vaccination) ces niveaux sont assez semblables dans toutes les espĂšces. On remarque toutefois, chez chacune d’elles, l’existence de sujets bons ou mauvais producteurs d’anticorps en proportion variable : plus Ă©levĂ©e chez les primates, plus rares chez les bovins. Chez l’homme cette rĂ©action individuelle, plus ou moins favorable, reste stable au cours des rappels annuels successifs.Levels of humoral immunity after vaccination against rabies were compared in man and four animal species (.monkeys, dogs, foxes and cattle) after 258 rabies virus neutralizing antibody titrations. Following one injection of primo-vaccination these levels were rather equi valent among the five species. However, in each of them, high and low responder animals were found in various amount: frequently among Primates, scarcely among cattle. This more or less effective responsiveness remained steady among people vaccinated yearly

    Antirabic vaccination of the fox by oral way

    No full text
    Les essais de vaccination par voie orale contre la rage de 117 renards roux ( Vulpes vulpes ) sont rapportĂ©s, leurs rĂ©sultats Ă©tant jugĂ©s par le titrage des anticorps neutralisants suivis de l’épreuve virulente par une souche sauvage. Ces essais ont employĂ© six souches diffĂ©rentes de virus rabique (Flury, « S AD. », «C.V.S.», « G.S./C », « Ts 0 55 » et « Av 01) non inactivĂ©es, modifiĂ©es par passages in vivo ou in vitro, et une souche de virus C V S. inactivĂ©e. Si cette derniĂšre n’a entraĂźnĂ© aucune protection aprĂšs dĂ©pĂŽt direct dans la gueule des renards, d’autres se sont avĂ©rĂ©es capables d’immuniser le renard Ă  condition d’ĂȘtre employĂ©es Ă  un titre suffisant. L’étude complĂšte de l'innocuitĂ© de ces virus, pour les espĂšces « non cibles », reste toutefois un prĂ©alable indispensable Ă  leur emploi pratique.Trials of oral vaccination against rabies are reported in 117 red foxes (Vulpes vulpes), their results being evaluated by titration of antibodies and challenge with a wild strain. These trials used six different strains of rabies virus (Flury, S.A.D., C.V.S., G.S./C., Ts O 55 and Av 0 1) living, modified by serial passages in vivo or in vitro, and one inactivated C.V.S. strain. This last did not protect foxes after direct deposit in their mouth, but living virus did, provided they were used at sufficient titres. However safety test of these virus, for non target species, remain to be achieved before their practical use in the field
    corecore